| Net loss | 4.15M |
| Depreciation and amortization | 1.41M |
| Amortization of premium/discount on marketable securities, net | |
| Amortization of debt discount | |
| Gain on sale of marketable securities | |
| Purchased in-process research and development | |
| Share-based compensation expense | |
| Common stock issued in exchange for services provided | |
| Loss on property and equipment | |
| Accounts receivable | -12.68M |
| Prepaid expenses and other assets | -19.37M |
| Accounts payable | -4.43M |
| Accrued liabilities | 7.38M |
| Deferred revenue | -2.1M |
| Deferred rent | |
| Net cash used in operating activities | -4.92M |
| Purchase of property and equipment | -1.12M |
| (Payments for) proceeds from disposal or sale of property and equipment | |
| Purchase of marketable securities | -2.64M |
| Proceeds from sales of marketable securities | |
| Proceeds from maturities of marketable securities | 2.64M |
| Net cash provided by (used in) investing activities | -1.12M |
| Issuance of common stock, net of issuance costs | |
| Exercise of stock options and stock purchase rights | 18.23M |
| Proceeds from related party notes payable | |
| Proceeds from note payable | |
| Issuance of convertible preferred stock, net of issuance costs | |
| Payments under capital lease obligations | |
| Repayment of notes payable | |
| Net cash provided by financing activities | 35.69M |
| (Decrease)/Increase in cash and cash equivalents | 29.65M |
| Cash and cash equivalents at beginning of period | 845.04M |
| Cash and cash equivalents at end of period | 874.68M |
| Accounts payable for property and equipment purchases | 793K |
| Accrued stock issuance costs | |
| Receivable for stock option exercises | |
| Settlement of related party notes payable by issuance of common stock | |
| Property and equipment acquired under capital lease obligations | |
| Warrants issued | |
| Conversion of notes payable and accrued interest into convertible preferred stock | |